bpc-157 interstitial cystitis pilot study BPC-157 and the Difference Between an Evidence Gap and Sample of patents with BPC

revised March 2012

When administered via injection, SLU-PP-332 demonstrates: Rapid absorption into the bloodstream High bioavailability, with a significant portion of the drug reaching systemic circulation Consistent absorption patterns across different patient populations These absorption characteristics contribute to the potential efficacy of SLU-PP-332 in various therapeutic applications

B12 is primarily found in animal-based foods such as meat, dairy, and eggs, and is absorbed in the small intestine after binding to a protein

Your AlluraMD provider administers the peptide through a subcutaneous injection during the procedure